Intelligent Ultrasound up as GE Healthcare launches AI product
Artificial intelligence-based software and simulation company Intelligent Ultrasound announced on Wednesday that GE Healthcare has launched its new AI-enhanced women's health ultrasound system, ‘Voluson SWIFT’.
The AIM-traded firm said the Voluson SWIFT features ‘SonoLyst’, which it describes as “the world's first” fully-integrated artificial intelligence (AI) AI tool that recognises the 20 views recommended by the International Society of Ultrasound in Obstetrics and Gynaecology mid-trimester practice guidelines for fetal imaging, and incorporates Intelligent Ultrasound's ‘ScanNav Assist’ AI technology.
It said SonoLyst features two applications that leveraged Intelligent Ultrasound's technology, ‘SonoLystIR’ and ‘SonoLystX’.
SonoLystIR performs automated detection of the key scanning views and automated selection of the relevant Voluson SonoBiometry measurement tools, and SonoLystX - a “virtual on-board ultrasound expert” - uses AI to compare the acquired image to standardised criteria, to ensure that it meets clinical standards.
SonoLystX helps to enhance accuracy and quality and was ideal for teaching, training and quality assurance, the board explained, to ensure the highest quality image standards and consistency.
It said SonoLyst was the first AI software to be launched under the group's long-term licence and co-development agreement with GE Healthcare, which enables the integration of Intelligent Ultrasound's real-time AI image analysis software into GE Healthcare's Voluson women's health ultrasound portfolio.
The first royalty per unit revenues for Intelligent Ultrasound were expected at the start of 2021.
“It has been a pleasure to work with GE over the last year to bring this new AI technology to market,” said chief executive officer Stuart Gall.
“The new Voluson SWIFT ultrasound system uses radical innovations such as SonoLyst to bring new levels of efficiency to obstetric ultrasound scanning.
“We are excited about our continuing collaboration to bring the latest AI solutions to the market and wish GE Healthcare every success with what we think is the future of ultrasound scanning in women's healthcare.”
At the close on Wednesday, shares in Intelligent Ultrasound Group were up 14.04% at 16.25p.